Growth Metrics

Galectin Therapeutics (GALT) Assets (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Galectin Therapeutics 165.77 Mn 151.67 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -19.32%
Dec 31, 2025 51.82%
Sep 30, 2025 -17.54%
Jun 30, 2025 63.75%
Mar 31, 2025 -45.54%
Dec 31, 2024 -39.61%
Sep 30, 2024 4.76%
Jun 30, 2024 6.82%
Mar 31, 2024 -8.19%
Dec 31, 2023 27.24%
Sep 30, 2023 10.37%
Jun 30, 2023 -0.71%
Mar 31, 2023 -4.98%
Dec 31, 2022 18.82%
Sep 30, 2022 -30.80%
Jun 30, 2022 -22.99%
Mar 31, 2022 -19.63%
Dec 31, 2021 9.96%
Sep 30, 2021 13.87%
Jun 30, 2021 45.89%
Mar 31, 2021 -22.65%
Dec 31, 2020 -13.07%
Sep 30, 2020 -17.59%
Jun 30, 2020 -6.33%
Mar 31, 2020 -8.99%
Dec 31, 2019 -4.52%
Sep 30, 2019 -4.25%
Jun 30, 2019 577.04%
Mar 31, 2019 -13.06%
Dec 31, 2018 -15.17%
Sep 30, 2018 -5.30%
Jun 30, 2018 127.34%
Mar 31, 2018 18.51%
Dec 31, 2017 -40.65%
Sep 30, 2017 -24.85%
Jun 30, 2017 -33.35%
Mar 31, 2017 -11.38%
Dec 31, 2016 -1.99%
Sep 30, 2016 -11.68%
Jun 30, 2016 -19.93%
Mar 31, 2016 -13.71%
Dec 31, 2015 22.76%
Sep 30, 2015 -19.37%
Jun 30, 2015 -10.99%
Mar 31, 2015 1.00%
Dec 31, 2014 -5.24%
Sep 30, 2014 -9.47%
Jun 30, 2014 -6.25%
Mar 31, 2014 244.43%
Dec 31, 2013 9.57%
Sep 30, 2013 87.12%
Jun 30, 2013 -27.39%
Mar 31, 2013 -24.74%
Dec 31, 2012 -14.58%
Sep 30, 2012 -15.98%
Jun 30, 2012 -14.26%
Mar 31, 2012 135.00%
Dec 31, 2011 -18.40%
Sep 30, 2011 -0.70%